SCHEMBL2036444

SCHEMBL2036444

C=C(C)COC(C)N1C(=O)CCC1=O

nearest known ligand 0.32

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
SLC1A2 P43004 1/20 0.32
CHRM2 P08172 1/20 0.32
CHRM4 P08173 1/20 0.32
CHRM5 P08912 1/20 0.32
CHRM1 P11229 1/20 0.32
CHRM3 P20309 1/20 0.32
KMT2A Q03164 2/20 0.31
ATM Q13315 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6817436 0.79 ALDH1A1 (0.30)
SCHEMBL6914620 0.77 LMNA (0.43) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL16694971 0.76
SCHEMBL8865252 0.75 CHRM2 (0.36) SLC1A2CHRM2CHRM4CHRM5CHRM1
SCHEMBL2030884 0.73 ALDH1A1 (0.50) KMT2A
SCHEMBL2036449 0.71 KMT2A (0.43) SLC1A2CHRM2CHRM4CHRM5CHRM1
SCHEMBL6680682 0.70 KMT2A (0.31) KMT2A
SCHEMBL406639 0.70 CHRM2 (0.34) SLC1A2CHRM2CHRM4CHRM5CHRM1
SCHEMBL263555 0.69 ALOX12 (0.36) KMT2AATM
SCHEMBL8024903 0.69 CHRM2 (0.36) SLC1A2CHRM2CHRM4CHRM5CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4637985-A1 A METHOD OF MAKING MICROCAPSULES COMPRISING A POLYMERIZED CORE AND THE USE OF THE SAME Calyxia (FR) 2025-10-29 EP disclosed
EP-3548521-B1 METHOD TO PREPARE MICROCAPSULES AND MICROPARTICLES CALYXIA (FR) 2025-03-26 EP disclosed
EP-3600641-B1 METHOD FOR PREPARING CAPSULES COMPRISING AT LEAST ONE WATER-SOLUBLE OR HYDROPHILIC SUBSTANCE AND CAPSULES OBTAINED THEREFROM CALYXIA (FR) 2025-02-12 EP disclosed
WO-2024133578-A1 A METHOD OF MAKING MICROCAPSULES COMPRISING A POLYMERIZED CORE AND THE USE OF THE SAME CALYXIA (FR) 2024-06-27 WO disclosed
EP-4389276-A1 A METHOD OF MAKING MICROCAPSULES COMPRISING A POLYMERIZED CORE AND THE USE OF THE SAME Calyxia (FR) 2024-06-26 EP disclosed
US-20240024236-A1 EMULSION COMPRISING SIZE-CONTROLLED DROPLETS CALYXIA (FR) 2024-01-25 US disclosed
WO-2023232993-A1 DOUBLE EMULSION AND CAPSULES CALYXIA (FR) 2023-12-07 WO disclosed
EP-4286040-A1 DOUBLE EMULSION AND CAPSULES Calyxia (FR) 2023-12-06 EP disclosed
EP-4255395-A1 EMULSION COMPRISING SIZE-CONTROLLED DROPLETS Calyxia (FR) 2023-10-11 EP disclosed
WO-2022117681-A1 EMULSION COMPRISING SIZE-CONTROLLED DROPLETS CALYXIA (FR) 2022-06-09 WO disclosed
EP-3144058-A1 METHOD FOR PREPARING MICROCAPSULES BY DOUBLE EMULSION Calyxia (FR) 2017-03-22 EP disclosed
US-20130137625-A1 Photo-Responsive Microencapsulation Materials, Compositions and Methods of Use Thereof SOLARBRE, INC. (US) 2013-05-30 US disclosed
US-8246869-B2 Photo-responsive microencapsulation materials, compositions and methods of use thereof SOLARBRE, INC. (US) 2012-08-21 US disclosed
US-7959990-B2 Adjustment of liquid crystals; oligomers, dendrimers, or polymer in solution is applied to support; crosslinking by radiation or polarized light ROLIC AG (CH) 2011-06-14 US disclosed
US-20090202652-A1 Photo-Responsive Microencapsulation Materials, Compositions and Methods of Use Thereof SOLARBRE, INC. (US) 2009-08-13 US disclosed
US-20080274304-A1 Functionalized Photoreactive Compounds ROLIC AG (CH) 2008-11-06 US disclosed
EP-1945344-A2 PHOTO-RESPONSIVE MICROENCAPSULATION MATERIALS, COMPOSITIONS AND METHODS OF USE THEREOF Solarbre, Inc. (US) 2008-07-23 EP disclosed
WO-2007051198-A2 PHOTO-RESPONSIVE MICROENCAPSULATION MATERIALS, COMPOSITIONS AND METHODS OF USE THEREOF SOLARBRE, INC (US) 2007-05-03 WO disclosed
WO-2006101746-A1 POSITIVE-WORKING, THERMALLY SENSITIVE IMAGEABLE ELEMENT EASTMAN KODAK COMPANY (US) 2006-09-28 WO disclosed
US-20060210917-A1 Positive-working, thermally sensitive imageable element KODAK POLYCHROME GRAPHICS LLC 2006-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090202652-A1 Photo-Responsive Microencapsulation Materials, Compositions and Methods of Use Thereof LIPA, LIPE, CRYAA SLC1A2 4246/4885CHRM2 1048/4885CHRM4 980/4885
US-20080274304-A1 Functionalized Photoreactive Compounds PCNA, PIN1, MAP1LC3C SLC1A2 1020/4885CHRM2 3643/4885CHRM4 3474/4885
US-20130137625-A1 Photo-Responsive Microencapsulation Materials, Compositions and Methods of Use Thereof LIPA, LIPE, CRYAA SLC1A2 4246/4885CHRM2 1048/4885CHRM4 980/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.